Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction

被引:94
作者
Ciavattini, Andrea [1 ]
Di Giuseppe, Jacopo [1 ]
Stortoni, Piergiorgio [1 ]
Montik, Nina [1 ]
Giannubilo, Stefano R. [1 ]
Litta, Pietro [2 ]
Islam, Md Soriful [3 ]
Tranquilli, Andrea L. [1 ]
Reis, Fernando M. [4 ,5 ]
Ciarmela, Pasquapina [3 ]
机构
[1] Polytech Univ Marche, Womans Hlth Sci Dept, Fac Med, Via Corridoni 11, I-60123 Ancona, Italy
[2] Univ Padua, Dept Gynaecol Sci & Human Reprod, I-35128 Padua, Italy
[3] Polytech Univ Marche, Dept Expt & Clin Med, Fac Med, I-60126 Ancona, Italy
[4] Univ Fed Minas Gerais, Dept Obstet & Gynecol, BR-30130100 Belo Horizonte, MG, Brazil
[5] Natl Inst Hormones & Womens Hlth, BR-30130100 Belo Horizonte, MG, Brazil
关键词
D O I
10.1155/2013/173184
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Uterine leiomyomas (fibroids or myomas) are benign tumors of uterus and clinically apparent in a large part of reproductive aged women. Clinically, they present with a variety of symptoms: excessive menstrual bleeding, dysmenorrhoea and intermenstrual bleeding, chronic pelvic pain, and pressure symptoms such as a sensation of bloatedness, increased urinary frequency, and bowel disturbance. In addition, they may compromise reproductive functions, possibly contributing to subfertility, early pregnancy loss, and later pregnancy complications. Despite the prevalence of this condition, myoma research is underfunded compared to other nonmalignant diseases. To date, several pathogenetic factors such as genetics, microRNA, steroids, growth factors, cytokines, chemokines, and extracellular matrix components have been implicated in the development and growth of leiomyoma. This paper summarizes the available literature regarding the ultimate relative knowledge on pathogenesis of uterine fibroids and their interactions with endometrium and subendometrial myometrium.
引用
收藏
页数:11
相关论文
共 154 条
  • [1] Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding
    Anania, CA
    Stewart, EA
    Quade, BJ
    Hill, JA
    Nowak, RA
    [J]. MOLECULAR HUMAN REPRODUCTION, 1997, 3 (08) : 685 - 691
  • [2] Transforming growth factor-β3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation
    Arici, A
    Sozen, I
    [J]. FERTILITY AND STERILITY, 2000, 73 (05) : 1006 - 1011
  • [3] Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-β1 in human myometrium and leiomyoma
    Arici, A
    Sozen, I
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 188 (01) : 76 - 83
  • [4] Prognostic importance of vascular endothelial growth factor and its receptors in the uterine sarcoma
    Arita, S
    Kikkawa, F
    Kajiyama, H
    Shibata, K
    Kawai, M
    Mizuno, K
    Nagasaka, T
    Ino, K
    Nomura, S
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (02) : 329 - 336
  • [5] Potential link between estrogen receptor-α gene hypomethylation and uterine fibroid formation
    Asada, Hiromi
    Yamagata, Yoshiaki
    Taketani, Toshiaki
    Matsuoka, Aki
    Tamura, Hiroshi
    Hattori, Naoko
    Ohgane, Jun
    Hattori, Naka
    Shiota, Kunio
    Sugino, Norihiro
    [J]. MOLECULAR HUMAN REPRODUCTION, 2008, 14 (09) : 539 - 545
  • [6] Onapristone suppresses prolactin production in explant cultures of leiomyoma
    Austin, DJ
    Nowak, RA
    Stewart, EA
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1999, 47 (04) : 268 - 271
  • [7] Baird DD, 2003, EPIDEMIOLOGY, V14, P247
  • [8] Vitamin D and the Risk of Uterine Fibroids
    Baird, Donna Day
    Hill, Michael C.
    Schectman, Joel M.
    Hollis, Bruce W.
    [J]. EPIDEMIOLOGY, 2013, 24 (03) : 447 - 453
  • [9] Barbarisi A, 2001, J CELL PHYSIOL, V186, P414, DOI 10.1002/1097-4652(2000)9999:999<000::AID-JCP1040>3.0.CO
  • [10] 2-E